Documente Academic
Documente Profesional
Documente Cultură
Dr Baharudin Abdullah
Dr VMK Bhavaraju
Dr Win Mar@ Salma
Dr Mutum S Singh
1 Dept of ORL-HNS, School of Medical Sciences, Univ. Sains Malaysia.
2 Dept of Nuclear Medicine, School of Medical Sciences, Univ. Sains Malaysia.
3 Dept of Radiology, School of Medical Sciences, Univ. Sains Malaysia.
4 Dept of Pathology, School of Medical Sciences, Univ. Sains Malaysia.
Case Presentation
Nasopharynx:
No obvious mass seen at fossa of
Rosenmuller or at the roof
Loose stroma, psammoma body
Stained with vimentin and EMA-differentiate from glioma, schwannoma
Patient underwent a tumor debulking via a
transparotid approach and received post operative
radiation to the residual tumor
A dose of 45 Gy/25#/5 weeks delivered by a 6 Mv
Linear Accelerator
Post operative Irradiation is given to reduce the
local recurrence
To prolong the disease free survival
A dose to be delivered depend on the normal tissue
tolerance
In the present case cervical spinal cord is the
limiting factor for the radical dose of radiation to be
delivered
Type 1 –direct extension from intracranial tumor
through foramina
Type 2 –extra cranial growth from arachnoid within
the cranial nerve sheath
Type 3- extra cranial growth from ectopic or embryonic
cell rest arachnoid without connection to skull base or
cranial nerve
Type 4 – distant metastases from intracranial
meningioma
1. Nasopharyngeal Carcinoma
2. Laryngeal Carcinoma
3. Oral cavity Cancers
4. Thyroid Cancer
5. Salivary Gland Cancer
6. Skin Cancers of Head and Neck
7. etc. such as Ca Ear, Ca Nose and Paranasal
Sinuses
6th most common cancer worldwide
HNSCC ~ 5% all cancers
SCC most common upper aerodigestive tract
malignancy
Smoking and alcohol
Management presents considerable functional
and aesthetic problems
Multidisciplinary approach imperative
Complete History
Physical examination
Endoscopic assessment of upper aerodigestivetract.
Imaging studies US/CT scan
Biopsy
Treatment
Rim enhancement
Central necrosis
Nodal size > 1cm
Obliteration of tissue planes
FNAVery accurate
Open Biopsy
–Should be avoided
–Can complicate future therapy
Safe
Rapid
Inexpensive
Presurgicalplanning, patient counselling.
Avoids open biopsy
No evidence of tumour seeding in HAN
Safe
Rapid
Inexpensive
Presurgicalplanning,
patient counselling.
Avoids open biopsy
No evidence of
tumour seeding in
HAN
Primary tumour+ cervical nodes
Surgery/DXRT/Chemotherapy
Sometimes palliation
Cervical neck disease reduces survival by 50%
Cancers of the oral cavity are treated by primary
surgical resection. Adjuvant radiotherapy or
concurrent chemoradiation is indicated for high-risk
group.
Tumors of the pharynx (oropharynx or hypopharynx)
are treated primarily with combined chemoradiation.
Laryngeal cancers are also treated with chemoradiation
if the larynx is functional. However, if the tumor has
destroyed the laryngeal skeleton, surgery may be
required to restore an adequate airway and maintain
swallowing.
Symptoms & Signs - Persistent SOM
- Neck Mass (Laterally at level 2)
- Nasal S&S - Nasal obstruction
- Nose Bleed or Bloody discharge
- etc.
- Cranial Nerve 5, 6, 9, 10, 11 and 3 & 4
- Miscellaneous - Headache
- Feeling lump in throat
Treatment - Radiation is a major role
- External
- Brachy therapy
- Stereotactic Radiation or Gamma knife
- Chemotherapy is an adjunctive modality
- Surgery - Eradicate residual lymphnodes or
primary resectable disease
- PDT
- etc
The WHO classification based on the degree of differentiation.
Type I: keratinizing squamous cell carcinoma (SCC), similar to
other head and neck cancer.
Type II: nonkeratinizing carcinoma (IIa)
Type III: undifferentiated carcinoma, has a typical morphology
with a prominent lymphoplasmacytic infiltrate, and is also
referred as “lymphoepithelioma.” (IIb)
In endemic areas, WHO Type III accounts for more than 97%,
while keratinizing SCC is more common in the Western countries
(~75%).
Latent EBV infection is uniquely present in almost all NPC from
endemic regions, but absent in WHO Type I NPC from non-
endemic regions.
Baharudin Abdullah
Shahid Hassan
Department of ORL-HNS
School of Medical Sciences
Universiti Sains Malaysia
Introduction
Recurrent JNA - 03
Chordoma - 01
Recurrent NPC - 03
Hospitals - procedure carried out
Hospital Universiti Sains Malaysia 07 Cases
Superior Transcranial
Inferior Transpalatal
Lateral Infratemporal
Anterior Transantral
Anterolateral Maxillary Swing
Exposure Achieved in C.S.Base
Recurrent NPC
Not eroding S.B.
No neck metastasis
Tumor not > 2 cm in size
Result - NPC
Trismus 01 case
-Hurthle Cell
-Medullary
-Anaplastic
-Malignant Lymphoma
I.Epithelial tumour:
A. Benign- follicular adenoma (90%), Hurtle cell adenoma (10%)
B. Malignant- Papillary (80%), follicular (10%), Hurtle cell (3%),
Medullary(5%);Anaplastic(1%), squamous cell car.
II. Nonepithelial
III.Malignant lymphoma
IV.Miscellaneous e.g teratomas
V. Secondary tumours
VI.Unclassified tumours
VII. Tumour-like lesions e.g thyroiditis, thyroid cysts, hyperplastic
goitres, amyloid goitres.
Commonest as a solitary thyroid nodule (10%
incidence malignant; increase after 50-60 years
of age ;males)
-cervical lymphadenopathy(20%)
-rapidly enlarging goitre
-pain in the neck ,stridor ,dysphagia ,
hoarseness, evidence of metastasis
Majority of malignancy-euthyroid
Family history and other tumours –in MEN
Past history of ionising radiation
Family history of thyroid cancer
History of previous thyroid cancer
Rapidly growing or painful
Male pt
Presence of neck or distant metastasis
Hard, fixed nodule with vocal cord paralysis or
recurrence cystic nodule
Under age of 14 or over 65 years of age
Multidisciplinary
Selection of combination modalities depend on
extent of disease, the prognostic factors and
risk group analysis
Treatment modalities
1.Surgery
2.Radioactive iodine
3.External beam radiotherapy
4.Thyroxine therapy
5.Chemotherapy
-total lobectomy-complete removal of one thyroid lobe and the
isthmus
-near-total thyroidectomy :total lobectomy and isthmusectomy with
removal of more than 90% contralateral lobe
-total thyroidectomy: removal of both thyroid lobes and isthmus
Minimum operation for suspected or confirmed thyroid cancer is
total lobectomy on side of lesion; often, near total thyroidectomy
performed initially.
1.Adenomas
2.Carcinomas
3.Non-epithelial tumours
4.Malignant lymphomas
5.Secondary tumours
6.Unclassified tumours
3 % of head and neck malignant tumours
80 % occur in parotid gland
10 % occur in the submandibular gland
10 % occur in sublingual gland and the minor
salivary glands
Benign tumors are more common
Sublingual 70%
Submandibular 40%
Parotid 20 %
Benign
Pleomorphic adenoma 80%
Monomorphic adenoma
Adenolymphoma
Oxyphil adenoma(oncocytoma)
Others
Malignant
Mucopidermoid
Adenoid cystic
Acinic cell ca
Adenoca
Malignant
Epidermoid
Ca in pleomorphic adenoma
Rare: squamous cell, undifferentiated ca
40% of malignant tumours at all salivary types
Infiltrative growth
Marked tendency to invade nerve
8% with Lnpathy at presentation
Mets-lungs
Most common childhood tumour
4-9 % of malignant tumours
Composed of epidermoid and mucous cells
Solid or cystic
90% or more tumour cells-high grade
40 % LNpathy
2.5-4% of tumors
Predominantly parotid
From terminal tubular intercalated duct
Maybe bilateral
Slow growing
Local recurrence and mets after a long disease
free interval are common
Malignant lymphoma
Unclassified tumors
1-3% in Head & Neck Cancer
Squamous cell carcinoma
Lymphoreticular tumors
Ethesioneuroblastoma
Minor salivary gland tumors
Melanoma
Cause & Risk Factors - Environment
- nickel refiners
- petroleum refiners
- woodworkers
- leather workers
- textile workers
- Genetic
Symptoms & Signs
- Nasal obstruction
- Bloody discharge
- Facial pain
- Foul smell
61st Annual General and Scientific Meeting
of the NZ Society of ORL-HNS
Baharudin Abdullah 1
Shamim Ahmed Khan1
Hillol K Pal 2
1 Dept of ORL-HNS, School of Medical Sciences, Universiti
Science Malaysia, 16150 K.Kerian, Kelantan, Malaysia
2 Dept of Neuroscience, School of Medical Sciences,